Pancreatic Cancer UK is encouraging people with advanced pancreatic cancer in Middlesbrough to find out more about a pioneering clinical trial at The James Cook University Hospital, which is offering a new combination of treatments which could ultimately allow patients to live for longer. The new HALO 301 trial could offer patients with pancreatic cancer that has spread outside the pancreas, a potential new treatment option for a disease which currently has very few treatments.
Cardiologists at Teesside’s biggest hospital have been praised for their role in a major international study looking at the effectiveness of different treatments for patients with Ischemic Heart Disease (IHD).
The cardiothoracic team, led by Dr Mark de Belder at The James Cook University Hospital, were praised by New York University-based leaders of the ISCHEMIA trial, a major international, multicentre randomised trial researching the best way to manage the condition.
A successful project to provide intravenous (IV) antibiotics to patients with a long-term lung condition in their own homes is set to benefit dozens of others with different health conditions. The cutting-edge service improvement enterprise looked at how providing IV antibiotic therapy to patients in their own homes rather than as inpatients in hospital could improve both the patient experience and also reduce costs.
A new hub which acts as a launch-pad for research, innovation and collaboration between health, technology and science has been launched for the first time at South Tees Hospitals NHS Foundation Trust in partnership with the Northern Health Science Alliance and the Centre for Process Innovation. We’ve also welcomed our first tenant GlycoSeLect UK into its new home at the Institute for Learning, Research and Innovation on The James Cook University Hospital site.
South Tees has installed the first Siemens ‘Symbia Evo’ gamma camera in the country at The James Cook University Hospital. Based in the nuclear medicine department at the Middlesbrough hospital, the £250,000 investment is to replace the existing camera which had done a sterling job over the last 13 years.
A specialist in diabetic foot disease at The James Cook University Hospital has been awarded £30,000 for research funding – which could help prevent patients having to go through the trauma of amputation. Dr Simon Ashwell and podiatry colleague Emma Scott took the coveted prize at South Tees Hospitals NHS Foundation Trust’s Dragons’ Lair event, run by the Research and Development team.
The James Cook University Hospital’s world renowned cardiology unit has become the first to treat heart failure patients using a new wireless pacemaker the size of a grain of RICE.
A handful of seriously ill patients at The James Cook University Hospital in Middlesbrough were the first to benefit from the potentially lifesaving new technology, which could revolutionise surgery for heart failure.
The James Cook University Hospital is very proud to be the first hospital in the North of England to recruit suitable patients to the Prostate Advances in Comparative Evidence (PACE) trial for prostate cancer. This trial is looking at a type of radiotherapy called stereotactic radiotherapy and comparing it with either conventional radiotherapy or surgery. The trial is for men who have been diagnosed with prostate cancer that has not grown outside the prostate gland.